Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
BHC Bausch Health
8.380-0.140-1.64%
Close
01/27 16:00 ET
8.390+0.010+0.12%
Post Mkt Price 01/27 19:35 ET
High
8.720
Open
8.490
Turnover
39.86M
Low
8.360
Pre Close
8.520
Volume
4.68M
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Bausch Health Cos. Inc. Stock Falls Friday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bausch Health Cos. Inc. BHC slipped 1.59% to C$11.15 Friday, in what proved to be an otherw
Bausch Health Companies (TSE:BHC) Trading Up 0.9%
Bausch Health Companies Inc. (TSE:BHC – Get Rating) was up 0.9% on Thursday . The company traded as high as C$11.77 and last traded at C$11.33. Approximately 598,753 shares changed hands during mid-d
Bausch Health Cos. Inc. Stock Rises Thursday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bausch Health Cos. Inc. BHC inched 0.89% higher to C$11.33 Thursday, in what proved to be a
Bausch Health Cos. Inc. Stock Rises Wednesday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bausch Health Cos. Inc. BHC inched 0.36% higher to C$11.23 Wednesday, in what proved to be
Global Psoriasis Therapeutics Market Report to 2031 - Featuring Abbvie, Amgen, Bausch Health, LEO Pharma and Novan Among Others
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Psoriasis Therapeutics Market By Drug Class, By Type, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has
Bausch Health Cos. Inc. Stock Rises Tuesday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bausch Health Cos. Inc. BHC advanced 2.10% to C$11.19 Tuesday, in what proved to be an othe
Age-Related Macular Degeneration (AMD) Global Market Report 2022: Featuring F. Hoffman - La Roche, Bayer, Abbvie, GSK, Novartis, Regeneron Pharmaceuticals, Bausch Health & Alimera Sciences
Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration (AMD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has
Bausch Health Cos. Inc. Stock Rises Monday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bausch Health Cos. Inc. BHC inched 0.74% higher to C$10.96 Monday, in what proved to be an
Bausch Health Companies Inc. (NYSE:BHC) Short Interest Down 14.1% in December
Bausch Health Companies Inc. (NYSE:BHC – Get Rating) saw a significant drop in short interest in the month of December. As of December 30th, there was short interest totalling 26,620,000 shares, a d
Bausch Health Companies Sees Unusually High Options Volume (NYSE:BHC)
Bausch Health Companies Inc. (NYSE:BHC – Get Rating) was the recipient of some unusual options trading activity on Friday. Stock traders bought 22,560 put options on the company. This represents an
Company Overview
More
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Salix segment consists of sales in the U.S. of GI products. The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.
CEO： Mr. Thomas Appio
Market： NYSE
Listing Date： 12/12/1996
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet